SILENCE THERAPEUTICS PLC

Company number 02992058

Date	Type	Description	View / Download
08 Jul 2019	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(2 pages)
13 May 2019	AA	Group of companies' accounts made up to 31 December 2018	(83 pages)
25 Apr 2019	TM01	Termination of appointment of Stephen Barry Parker as a director on 25 April 2019	(1 page)
25 Apr 2019	AP01	Appointment of James Lawrence Ede-Golightly as a director on 25 April 2019	(2 pages)
25 Apr 2019	AP01	Appointment of Mr Iain Gladstone Ross as a director on 25 April 2019	(2 pages)
17 Apr 2019	TM01	Termination of appointment of Andrew John Mcglashan Richards as a director on 16 April 2019	(1 page)
09 Jan 2019	AP03	Appointment of Dr Robert Quinn as a secretary on 9 January 2019	(2 pages)
09 Jan 2019	TM01	Termination of appointment of David John Ellam as a director on 9 January 2019	(1 page)
09 Jan 2019	TM02	Termination of appointment of David John Ellam as a secretary on 9 January 2019	(1 page)
25 Sep 2018	TM01	Termination of appointment of Annalisa Jenkins as a director on 20 August 2018	(1 page)
24 Aug 2018	CS01	Confirmation statement made on 24 August 2018 with updates	(4 pages)
18 Jul 2018	AP01	Appointment of Dr David Horn Solomon as a director on 17 July 2018	(2 pages)
18 Jul 2018	AP01	Appointment of Mr Dave Lemus as a director on 21 June 2018	(2 pages)
04 Jun 2018	TM01	Termination of appointment of Ali Mortazavi as a director on 4 June 2018	(1 page)
02 May 2018	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(3 pages)
10 Apr 2018	AA	Group of companies' accounts made up to 31 December 2017	(75 pages)
16 Oct 2017	AP01	Appointment of Dr Annalisa Jenkins as a director on 16 October 2017	(2 pages)
13 Oct 2017	CS01	Confirmation statement made on 13 October 2017 with updates	(4 pages)
03 Aug 2017	PSC01	Notification of Richard Griffiths as a person with significant control on 27 July 2017	(2 pages)
03 Aug 2017	PSC09	Withdrawal of a person with significant control statement on 3 August 2017	(2 pages)
24 Jul 2017	PSC08	Notification of a person with significant control statement	(2 pages)
28 Jun 2017	AA	Group of companies' accounts made up to 31 December 2016	(71 pages)
26 Jun 2017	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(3 pages)
16 Nov 2016	CS01	Confirmation statement made on 14 November 2016 with updates	(5 pages)
16 Nov 2016	AP01	Appointment of Dr Andrew John Mcglashan Richards as a director on 14 September 2016	(2 pages)